DUNAD THERAPEUTICS LTD.
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Dunad Therapeutics Ltd.: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Dunad Therapeutics Ltd. sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
DUNAD THERAPEUTICS LTD. is an active private limited company (company number 12544797) incorporated on 2 April 2020, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest group accounts cover the period ending 31 December 2025, showing net assets of −£2.25m and cash of £287k, with 7 employees on average. Net assets fell 126% on the prior period (£8.69m).
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
Ownership and control
No active person with significant control is registered.
- Ms Vanessa Lea Mcminn
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dziyana Kraskouskaya
- holds 25–50% of voting rights
- Epidarex Capital Iii Uk, Lp
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 2 April 20206 yrs ago
- Next accounts due
- 30 September 2027in 338 days
- Confirmation statement due
- 16 April 2027in 171 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Group
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£2.25m | £287k | — | £490k | — | −£11.73m | 7 |
| 31 December 2024 | £8.69m | £8.00m | £1.56m | — | — | −£12.77m | 10 |
| 1 January 2024 | — | — | — | — | — | — | — |
| 31 December 2023 | £11.25m | £11.62m | £3.89m | — | — | −£11.49m | 13 |
| 31 December 2022 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-2,248,361 at 31 December 2025
- Net assets down 25% or more on the prior period-125.9% vs prior period
- Cash at bank of £50,000 or moreCash £287,459
- Three or more accounting periods on record5 periods on record
- Incorporated five or more years agoIncorporated 2 April 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 338 days
- Confirmation statement duein 171 days
- Accounts period endNet liabilities £2.25m · group accounts
- Accounts period endNet assets £8.69m · group accounts
- Accounts period end
- Accounts period endNet assets £11.25m · group accounts
- Accounts period end
- Incorporated
Similar companies in Cambridge
- EXOSLA LIMITEDCambridge · inc. Mar 2020
- ASTREA UK SERVICES LIMITEDComberton · inc. Apr 2020
- MESTAG THERAPEUTICS LTDSaffron Walden · inc. Feb 2020
- IMHOTEX LIMITEDCambridge · inc. Feb 2020
- ABBEXA LABORATORIES LTDCambridge · inc. Jun 2020
- BIOCERA MEDICAL LIMITEDHaverhill · inc. Jan 2020
All companies incorporated on 2 April 2020 · in Apr 2020.
Reminders for DUNAD THERAPEUTICS LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.